XML 53 R19.htm IDEA: XBRL DOCUMENT
v3.5.0.2

Share-based Payments | 6 Months Ended
--- | ---
Jun. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
Share-based Payments | Share-based Payments Share-based Compensation Expense The following table summarizes share-based compensation expense included in our condensed consolidated statements of income:
| For the Three Months Ended June 30, |  | For the Six Months Ended June 30,
(In millions) | 2016 |  | 2015 |  | 2016 |  | 2015
Research and development | $ | 21.5 |  |  | $ | 22.1 |  |  | $ | 42.9 |  |  | $ | 57.5 |
Selling, general and administrative | 28.7 |  |  | 26.2 |  |  | 63.4 |  |  | 81.8 |
Restructuring charges | — |  |  | — |  |  | (1.8 | ) |  | — |
Subtotal | 50.2 |  |  | 48.3 |  |  | 104.5 |  |  | 139.3 |
Capitalized share-based compensation costs | (4.4 | ) |  | (2.2 | ) |  | (7.5 | ) |  | (5.6 | )
Share-based compensation expense included in total cost and expenses | 45.8 |  |  | 46.1 |  |  | 97.0 |  |  | 133.7 |
Income tax effect | (12.7 | ) |  | (12.9 | ) |  | (27.9 | ) |  | (39.6 | )
Share-based compensation expense included in net income attributable to Biogen Inc. | $ | 33.1 |  |  | $ | 33.2 |  |  | $ | 69.1 |  |  | $ | 94.1 |
The following table summarizes share-based compensation expense associated with each of our share-based compensation programs:
| For the Three Months Ended June 30, |  | For the Six Months Ended June 30,
(In millions) | 2016 |  | 2015 |  | 2016 |  | 2015
Market stock units | $ | 7.9 |  |  | $ | 9.1 |  |  | $ | 21.3 |  |  | 26.1 |
Time-vested restricted stock units | 33.9 |  |  | 31.8 |  |  | 64.0 |  |  | 63.7 |
Cash settled performance units | 4.6 |  |  | 3.2 |  |  | 4.8 |  |  | 27.0 |
Performance units | 1.3 |  |  | 1.2 |  |  | 8.2 |  |  | 14.4 |
Employee stock purchase plan | 2.5 |  |  | 3.0 |  |  | 6.2 |  |  | 8.1 |
Subtotal | 50.2 |  |  | 48.3 |  |  | 104.5 |  |  | 139.3 |
Capitalized share-based compensation costs | (4.4 | ) |  | (2.2 | ) |  | (7.5 | ) |  | (5.6 | )
Share-based compensation expense included in total cost and expenses | $ | 45.8 |  |  | $ | 46.1 |  |  | $ | 97.0 |  |  | $ | 133.7 |
We estimate the fair value of our obligations associated with our performance units and cash settled performance units at the end of each reporting period through expected settlement. Cumulative adjustments to these obligations are recorded each quarter to reflect changes in the stock price and estimated outcome of the performance-related conditions. Grants Under Share-based Compensation Plans The following table summarizes our equity grants to employees, officers and directors under our current stock plans:
| For the Six Months Ended June 30,
| 2016 |  | 2015
Market stock units | 166,000 |  |  | 179,000 |
Cash settled performance shares | 86,000 |  |  | 115,000 |
Performance units | 56,000 |  |  | 89,000 |
Time-vested restricted stock units | 594,000 |  |  | 375,000 |
Employee Stock Purchase Plan (ESPP) In June 2015, our stockholders approved the Biogen Inc. 2015 ESPP (2015 ESPP). The 2015 ESPP, which became effective on July 1, 2015, replaced the Biogen Idec Inc. 1995 ESPP (1995 ESPP), which expired on June 30, 2015. The maximum aggregate number of shares of our common stock that may be purchased under the 2015 ESPP is 6,200,000. For the six months ended June 30, 2016, approximately 109,000 shares were issued under our 2015 ESPP, compared to approximately 98,000 shares issued under our 1995 ESPP in the prior year comparative period.

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 40 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=65895303&loc=d3e17540-113929 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=68057994&loc=d3e25284-112666 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 14) -URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration